ALK and neuroblastoma: In addition to telomere maintenance mechanisms, mutations in genes related to the RAS pathway, such as the anaplastic lymphoma kinase (ALK) gene, and the p53 pathway have been found to contribute to neuroblastoma pathogenesis and to be associated with a poor clinical outcome, in particular in the presence of telomere maintenance mechanisms [2, 8, 9].